Vigmed announced today that they are continuing to sign exclusive distribution
agreements across Europe – the most recent with Mediq Suisse AG.
Following a row of announcements of signed agreements for most of the Western
European markets, and last week’s distribution agreement for the important
German market, Vigmed is now adding Switzerland to their rapidly expanding
network of distributors. This completes the distribution agreements for the
German speaking area (DACH) for the unique and patented safety products from

“We are extremely pleased to welcome one of the companies within the strong
Mediq group to our family of distributors in Europe”, says Vigmed Sales
Director, Mike Dooley. “Mediq Suisse is a growing company and we are very much
looking forward to assist this growth by offering quality products which fit
with their goals of bringing safer products to the Swiss healthcare market.”

“I am confident that this is the start of a prosperous business relationship.
Our qualified team here in Switzerland is keen to start promoting these products
in 2015, and we look forward to helping to reduce needlestick injuries in the
country with the safety innovations Vigmed is providing”, says Ralph
Schönbächler, CEO Mediq Suisse.
For further information contact:

CEO, Finn Ketler 46 42 600 5311 or Sales Director Europe, Mike Dooley 46 42 600
Vigmed is a Swedish medical technology company whose mission is to eliminate
needlestick injuries by offering the market unique needle-protected products.
Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20
employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm
(ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the
Company’s Certified Advisor.

Additional information such as company description, a video presentation and
risk factors can be found on Vigmed’s website: